ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
9.81
+0.05 (0.51%)
At close: Jun 15, 2026, 4:00 PM EDT
9.95
+0.14 (1.43%)
Pre-market: Jun 16, 2026, 5:34 AM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $974.17 million as of June 16, 2026. Its market cap has decreased by -31.26% in one year.
Market Cap
974.17M
Enterprise Value
944.39M
1-Year Change
-31.26%
Ranking
Category
Stock Price
$9.81
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $974.17M, an increase of 71.43%. That is a compound annual growth rate of 16.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 974.17M | -15.41% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint | 1.09B |
| Absci | 1.06B |
| DBV Technologies | 1.03B |
| Corvus Pharmaceuticals | 1.00B |
| Seaport Therapeutics | 954.50M |
| Xencor | 914.17M |
| Pharming Group | 911.33M |
| Jade Biosciences | 910.58M |